Association of harm avoidance with dopamine D2/3 receptor availability in striatal subdivisions: A high resolution PET study

Biological Psychology

Volumn 87, Issue 1, 2011, Pages 164-167

  Kim, Jong Hoon ^a   Son, Young Don ^a   Kim, Hang Keun ^a   Lee, Sang Yoon ^a   Cho, Seo Eun ^a   Kim, Young Bo ^a   Cho, Zang Hee ^a  

^a Gachon University   (South Korea)

Author keywords

Dopamine D2 3 receptor; Harm avoidance; Positron emission tomography; Raclopride; Striatal subdivisions

Indexed keywords

CARBON 11; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; RACLOPRIDE;

ADULT; ARTICLE; AVOIDANCE BEHAVIOR; CAUDATE NUCLEUS; COGNITION; CONTROLLED STUDY; CORPUS STRIATUM; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN EXPERIMENT; LOCOMOTION; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERSONALITY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; SENSORIMOTOR CORTEX; TEMPERAMENT AND CHARACTER INVENTORY;

ADULT; BRAIN MAPPING; CARBON ISOTOPES; CORPUS STRIATUM; DOPAMINE ANTAGONISTS; FEMALE; HARM REDUCTION; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; POSITRON-EMISSION TOMOGRAPHY; RACLOPRIDE; RECEPTORS, DOPAMINE D2; STATISTICS AS TOPIC;

EID: 79953294120     PISSN: 03010511     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsycho.2011.02.011     Document Type: Article

References (24)

1. Cloninger C.R., Svrakic D.M., Przybeck T.R. A psychobiological model of temperament and character. Archives of General Psychiatry 1993, 50:975-990.
2. Farde L., Gustavsson J.P., Jonsson E. D2 dopamine receptors and personality traits. Nature 1997, 385:590.
3. Fei X., Mock B.H., DeGrado T.R., Wang J.Q., Glick-Wilson B.E., Sullivan M.L., et al. An improved synthesis of PET dopamine D2 receptors radioligand [11C]raclopride. Synthetic Communications 2004, 34:1897-1907.
4. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders Research Version (SCID-I) 1996, New York State Psychiatric Institute Biometrics Research, New York.
5. Grant K.A., Shively C.A., Nader M.A., Ehrenkaufer R.L., Line S.W., Morton T.E., et al. Effect of social status on striatal dopamine D2 receptor binding characteristics in cynomolgus monkeys assessed with positron emission tomography. Synapse 1998, 29:80-83.
6. Gründer G., Landvogt C., Vernaleken I., Buchholz H.G., Ondracek J., Siessmeier T., et al. The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia. Neuropsychopharmacology 2006, 31:1027-1035.
7. Haber S.N., McFarland N.R. The concept of the ventral striatum in nonhuman primates. Annals of the New York Academy of Sciences 1999, 877:33-48.
8. Hong I.K., Chung S.T., Kim H.K., Kim Y.B., Son Y.D., Cho Z.H. Ultra fast symmetry and SIMD-based projection-backprojection (SSP) algorithm for 3D PET image reconstruction. IEEE Transactions on Medical Imaging 2007, 26:789-803.
9. Kaasinen V., Nurmi E., Bergman J., Eskola O., Solin O., Sonninen P., et al. Personality traits and brain dopaminergic function in Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:13272-13277.
10. Kaplan J.R., Manuck S.B., Fontenot M.B., Mann J.J. Central nervous system monoamine correlates of social dominance in cynomolgus monkeys (Macaca fascicularis). Neuropsychopharmacology 2002, 26:431-443.
11. Kessler R.M., Ansari M.S., Riccardi P., Li R., Jayathilake K., Dawant B., et al. Occupancy of striatal and extrastriatal dopamine D2/D3 receptors by olanzapine and haloperidol. Neuropsychopharmacology 2005, 30:2283-2289.
12. Kestler L.P., Malhotra A.K., Finch C., Adler C., Breier A. The relation between dopamine D2 receptor density and personality: preliminary evidence from the NEO personality inventory-revised. Neuropsychiatry, Neuropsychology, and Behavioral Neurology 2000, 13:48-52.
13. Laakso A., Wallius E., Kajander J., Bergman J., Eskola O., Solin O., et al. Personality traits and striatal dopamine synthesis capacity in healthy subjects. American Journal of Psychiatry 2003, 160:904-910.
14. Logan J., Fowler J.S., Volkow N.D., Wang G.J., Ding Y.S., Alexoff D.L. Distribution volume ratios without blood sampling from graphical analysis of PET data. Journal of Cerebral Blood Flow and Metabolism 1996, 16:834-840.
15. Martinez D., Slifstein M., Broft A., Mawlawi O., Hwang D.R., Huang Y., et al. Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II. Amphetamine-induced dopamine release in the functional subdivisions of the striatum. Journal of Cerebral Blood Flow and Metabolism 2003, 23:285-300.
16. Martinez D., Orlowska D., Narendran R., Slifstein M., Liu F., Kumar D., et al. Dopamine type 2/3 receptor availability in the striatum and social status in human volunteers. Biological Psychiatry 2010, 67:275-278.
17. Mawlawi O., Martinez D., Slifstein M., Broft A., Chatterjee R., Hwang D.R., et al. Imaging human mesolimbic dopamine transmission with positron emission tomography. I. Accuracy and precision of D(2)receptor parameter measurements in ventral striatum. Journal of Cerebral Blood Flow and Metabolism 2001, 21:1034-1057.
18. Montag C., Markett S., Basten U., Stelzel C., Fiebach C., Canli T., et al. Epistasis of the DRD2/ANKK1 Taq Ia and the BDNF Val66Met polymorphism impacts novelty seeking and harm avoidance. Neuropsychopharmacology 2010, 35:1860-1867.
19. Morgan D., Grant K.A., Gage H.D., Mach R.H., Kaplan J.R., Prioleau O., et al. Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration. Nature Neuroscience 2002, 5:169-174.
20. Mukherjee J., Yang Z.Y., Das M.K., Brown T. Fluorinated benzamide neuroleptics-III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-[18F]fluoropropyl)-2,3-dimethoxybenzamide as an improved dopamine D-2 receptor tracer. Nuclear Medicine and Biology 1995, 22:283-296.
21. Pud D., Eisenberg E., Sprecher E., Rogowski Z., Yarnitsky D. The tridimensional personality theory and pain: harm avoidance and reward dependence traits correlate with pain perception in healthy volunteers. European Journal of Pain 2004, 8:31-38.
22. Tomer R., Aharon-Peretz J. Novelty seeking and harm avoidance in Parkinson's disease: effects of asymmetric dopamine deficiency. Journal of Neurology, Neurosurgery, and Psychiatry 2004, 75:972-975.
23. Wilson A.A., Garcia A., Jin L., Houle S. Radiotracer synthesis from [(11)C]-iodomethane: a remarkably simple captive solvent method. Nuclear Medicine and Biology 2000, 27:529-532.
24. Yasuno F., Suhara T., Sudo Y., Yamamoto M., Inoue M., Okubo Y., et al. Relation among dopamine D(2) receptor binding, obesity and personality in normal human subjects. Neuroscience Letters 2001, 300:59-61.